The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wilkins H Jeffrey since 2021.
This trader's CIK number is 1779160.
At the time of last reporting, Wilkins H Jeffrey was the Chief Medical Officer of Avalo Therapeutics, Inc.. (stock ticker symbol AVTX).
Also see all insider trading activities at Avalo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | AVTX | 6,371 | $10,002 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-10 | AVTX | Buy | 6,371 | 1.57 | 10,002 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wilkins H Jeffrey (Chief Medical Officer of Avalo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.